415 Capital

About

415 Capital is a venture capital firm based in Munich, Germany, specializing in investments in medical technologies that tackle life-threatening conditions. Founded in 2018, the firm has a global reach, with investments across Europe, the U.S., and Israel. With a team that boasts over 25 years of collective experience, 415 Capital has funded more than 50 medical technology startups and achieved over 25 successful exits through trade sales and IPOs. The firm offers venture capital financing, strategic guidance, and market access to early-stage MedTech companies. It supports product development, clinical trials, and commercialization while providing expertise in regulatory and clinical matters. 415 Capital leverages a global network of partnerships with key opinion leaders, hospitals, and research institutions to foster growth in its portfolio. Notable investments include companies focused on cardiovascular and neurovascular technologies, which collectively have raised over €600 million in follow-on financing. In October 2024, 415 Capital launched its €150 million Fund II, aimed at innovations in high-burden medical fields.

Benefits

• Venture capital financing for early-stage MedTech companies.
  Focus on cardiovascular and neurovascular technologies with successful follow-on financing.

Eligibility Criteria

• Early-stage medical technology startups.
• Focus on innovations in high-burden medical fields.
• Seeking funding, strategic guidance, and market access support.
• Open to startups across Europe, the U.S., and Israel.

Target Region

Global

Target Sector

MedTech, Healthcare, Surgical Robotics, BioTech